About P-Cure
P-Cure is a company based in Lod (Israel) founded in 2007 by Michael Marash. It operates as a HealthTech. P-Cure has raised $15 million across 1 funding round. P-Cure offers products and services including Gantry-Less Proton Therapy System. P-Cure operates in a competitive market with competitors including Advanced Oncotherapy, Terapet, B dot Medical, HIL Medical and Provision Healthcare, among others.
- Headquarter Lod, Israel
- Founders Michael Marash
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name P-Cure Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15 M (USD)
in 1 rounds
-
Latest Funding Round
$15 M (USD), Series B
Jul 16, 2019
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of P-Cure
P-Cure offers a comprehensive portfolio of products and services, including Gantry-Less Proton Therapy System.
Compact proton therapy system for cancer treatment provided.
People of P-Cure
Unlock access to complete
Funding Insights of P-Cure
P-Cure has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series B round of $15 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by P-Cure
Investment portfolio details for P-Cure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - P-Cure
Detailed financials for P-Cure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
P-Cure Comparisons
Peer comparison for P-Cure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of P-Cure
P-Cure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Oncotherapy, Terapet, B dot Medical, HIL Medical and Provision Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of proton beam therapy system for the treatment of cancer
|
|
| Locked | Locked | Locked |
Terapet is focused on developing imaging solutions for proton therapy.
|
|
| Locked | Locked | Locked |
Proton beam therapeutic devices for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Proton-beam radiotherapy devices are developed for solid tumor treatment.
|
|
| Locked | Locked | Locked |
Proton therapy system for cancer treatment is developed.
|
Detailed competitors of P-Cure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on P-Cure
Complete news archive for P-Cure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about P-Cure
P-Cure was founded in 2007 and raised its 1st funding round 12 years after it was founded.
P-Cure is headquartered in Lod, Israel. It is registered at Lod, Central District, Israel.
Michael Marash is the current CEO of P-Cure. They have also founded this company.
P-Cure is a funded company, having raised a total of $15M across 1 funding round to date.
P-Cure is engaged in the development and supply of compact proton therapy systems for cancer treatment. The company operates within the healthcare sector, focusing on medical devices for radiation therapy. Solutions are designed to fit existing linac-like vaults, offering treatment in both seated and supine positions. Operations are supported globally with platforms in the US, Israel, and China, ensuring accessibility and cost efficiency for oncology centers. Collaboration with healthcare providers is emphasized to achieve rapid return on investment.
P-Cure's top competitors include Advanced Oncotherapy, Terapet and HIL Medical.
P-Cure offers Gantry-Less Proton Therapy System.